Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Sakari Telimaa"'
Publikováno v:
Acta obstetricia et gynecologica Scandinavica. 68(S150)
Progestins, including medroxyprogesterone acetate (MPA), danazol and gestrinone, are used in the medical management of endometriosis. Danazol and gestrinone, by inducing progestin-like effects, closely resemble MPA in their actions on intrauterine en
Publikováno v:
International Journal of Pediatric Otorhinolaryngology. 36:205-213
On day 2 post partum, swab samples were obtained from the oropharyngx of 20 healthy, breast-fed babies. The samples were examined for aerobes (culture on agar plates), for bacterial coating with the immunoglobulins SIgA, IgG and IgM (immunofluorescen
Autor:
J. Heikkinen, Anja Virkkunen, Fredrika Pekonen, Anna-Maija Rautio, Helena Sundström, Torsten Wahlström, Salmi T, Elina Granfors, Sakari Telimaa, Erkki Hirvonen, G. Wilen-Rosenqvist, J. Puolakka, Leo Mäkäräinen, Seppo Hulkko, Simo Nummi
Publikováno v:
Maturitas. 21:39-44
We evaluated whether a progestin, added for 14 days every 3 months to estrogen replacement therapy, is capable of preventing the development of endometrial hyperplasia in postmenopausal women during a treatment period of 2 years. Postmenopausal women
Publikováno v:
European journal of obstetrics, gynecology, and reproductive biology. 36(1-2)
The hormonal and biochemical effects of danazol (600 mg a day) and high-dose medroxyprogesterone acetate (MPA; 100 mg a day) were studied in a placebo-controlled, 6-month trial. Serum gonadotrophins and prolactin levels did not change during danazol
Publikováno v:
Gynecological Endocrinology. 1:363-371
To evaluate the clinical value of postoperative hormone therapy in endometriosis, 60 patients with advanced disease were randomized to receive in a double-blind study danazol (200 mg, 3 times daily), medroxyprogesterone acetate (MPA) (100 mg daily) o
Publikováno v:
Fertility and Sterility. 49:37-41
Serum concentrations of CA-125 were determined in association with 6-month medical (n = 48) or surgical and medical therapy (n = 40) of endometriosis. The concentration of CA-125 was significantly higher in stages III + IV (66.6 +/- 22.0 [standard de
Publikováno v:
Gynecological Endocrinology. 1:13-23
A prospective, double-blind, placebo-controlled study was designed to evaluate the clinical efficacy and tolerance of danazol and high-dose medroxyprogesterone acetate (MPA) in the treatment of mild-moderate endometriosis. After laparoscopical confir
Autor:
Sakari Telimaa
Publikováno v:
Fertility and Sterility. 50:872-875
Danazol (200 mg three times a day) and medroxyprogesterone acetate (MPA, 100 mg a day) were compared with placebo in the treatment of infertility of patients with endometriosis. Twenty-seven patients had medical therapy alone for 6 months, and 22 pat
Publikováno v:
American Journal of Obstetrics and Gynecology. 161:866-871
The circulating concentration of endometrial protein PP14 varied during the menstrual cycle in patients with endometriosis. The highest levels were found on days 1 to 4 of the cycle (176 +/- 123 micrograms/L; mean +/- SD), and the lowest on days 5 to
Studies on cytosol endometrial estrogen and progestin receptor concentrations and 17s-hydroxysteroid dehydrogenase activity have shown that the effects of danazol and medroxyprogesterone acetate (MPA) are similar. Therefore we conducted a placebo-con
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5782cabcf25bb3402fe2df62e13d2b50
https://doi.org/10.1159/000414861
https://doi.org/10.1159/000414861